Match!

Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trial

Published on Oct 11, 2018in JAMA Oncology22.416
· DOI :10.1001/jamaoncol.2018.1212
Rowan T. Chlebowski80
Estimated H-index: 80
(City of Hope National Medical Center),
Aaron K. Aragaki42
Estimated H-index: 42
(Fred Hutchinson Cancer Research Center)
+ 10 AuthorsRoss L. Prentice102
Estimated H-index: 102
(Fred Hutchinson Cancer Research Center)
Abstract
Importance In a randomized clinical trial, a low-fat eating pattern was associated with lower risk of death after breast cancer. However, the extent to which results were driven by dietary influence on survival after breast cancer diagnosis was unknown. Objective To determine the association of a low-fat dietary pattern with breast cancer overall survival (breast cancer followed by death from any cause measured from cancer diagnosis). Design, Setting, and Participants This is a secondary analysis of the Women’s Health Initiative randomized clinical trial that was conducted at 40 US clinical centers enrolling participants from 1993 through 1998. Participants were 48 835 postmenopausal women with no previous breast cancer and dietary fat intake of greater than 32% by food frequency questionnaire. Interventions Participants were randomized to a dietary intervention group (40%; n = 19 541) with goals to reduce fat intake to 20% of energy and increase fruit, vegetable, and grain intake or a usual-diet comparison group (60%; n = 29 294). Dietary group participants with incident breast cancers continued to participate in subsequent dietary intervention activities. Main Outcomes and Measures Breast cancer overall survival for incident breast cancers diagnosed during the 8.5-year (median) dietary intervention, examined in post hoc analyses after 11.5 years (median) postdiagnosis follow-up. Results Of 1764 women diagnosed with breast cancer during the dietary intervention period, mean (SD) age at screening was 62.7 (6.7) years and age at diagnosis was 67.6 (6.9) years. With 516 total deaths, breast cancer overall survival was significantly greater for women in the dietary intervention group than in the usual-diet comparison group (10-year survival of 82% and 78%, respectively; hazard ratio [HR], 0.78; 95% CI, 0.65-0.94; P  = .01). In the dietary group there were fewer deaths from breast cancer (68 vs 120; HR, 0.86; 95% CI, 0.64-1.17), other cancers (36 vs 65; HR, 0.76; 95% CI, 0.50-1.17), and cardiovascular disease (27 vs 64; HR, 0.62; 95% CI, 0.39-0.99). Conclusions and Relevance In women who received a diagnosis of breast cancer during the dietary intervention period, those in the dietary group had increased overall survival. The increase is due, in part, to better survival from several causes of death. Trial Registration ClinicalTrials.gov Identifier:NCT00000611
  • References (33)
  • Citations (4)
📖 Papers frequently viewed together
2 Citations
25 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References33
Newest
#1Rowan T. Chlebowski (Los Angeles Biomedical Research Institute)H-Index: 80
#2Aaron K. Aragaki (Fred Hutchinson Cancer Research Center)H-Index: 42
Last. Ross L. Prentice (Fred Hutchinson Cancer Research Center)H-Index: 102
view all 17 authors...
PurposeEarlier Women’s Health Initiative Dietary Modification trial findings suggested that a low-fat eating pattern may reduce breast cancers with greater mortality. Therefore, as a primary outcome-related analysis from a randomized prevention trial, we examined the long-term influence of this intervention on deaths as a result of and after breast cancer during 8.5 years (median) of dietary intervention and cumulatively for all breast cancers diagnosed during 16.1 years (median) of follow-up.Pa...
19 CitationsSource
Often, studies modeling an exposure's influence on time to disease-specific death from study enrollment are incorrectly interpreted as if based on time to death from disease diagnosis. We studied 151,996 post-menopausal women without breast or colorectal cancer in the Women's Health Initiative with weight and height measured at enrollment (1993-1998). Using Cox regression models, we contrast hazard ratios (HR) from two time-scales and corresponding study subpopulations: time to cancer death afte...
2 CitationsSource
#1Sarah F. Brennan ('QUB': Queen's University Belfast)H-Index: 6
#2Jayne V. Woodside ('QUB': Queen's University Belfast)H-Index: 40
Last. Marie M. Cantwell ('QUB': Queen's University Belfast)H-Index: 31
view all 5 authors...
ABSTRACTBackground: The influence of dietary fat upon breast cancer mortality remains largely understudied despite extensive investigation into its influence upon breast cancer risk. Objective: To conduct meta-analyses of studies to clarify the association between dietary fat and breast cancer mortality. Design: MEDLINE and EMBASE were searched for relevant articles published up to March 2012. Risk of all-cause or breast-cancer-specific death was evaluated by combining multivariable adjusted est...
16 CitationsSource
#1Ross L. Prentice (Fred Hutchinson Cancer Research Center)H-Index: 102
#2Aaron K. Aragaki (Fred Hutchinson Cancer Research Center)H-Index: 42
Last. Barbara V. Howard (Georgetown University)H-Index: 116
view all 12 authors...
: Background: The influence of a low-fat dietary pattern on the cardiovascular health of postmenopausal women continues to be of public health interest.Objective: This report evaluates low-fat dietary pattern influences on cardiovascular disease (CVD) incidence and mortality during the intervention and postintervention phases of the Women's Health Initiative Dietary Modification Trial.Design: Participants comprised 48,835 postmenopausal women aged 50-79 y; 40% were randomly assigned to a low-fat...
15 CitationsSource
Over the past 40 years, the prevalence of obesity has increased epidemically worldwide, which raises significant concerns regarding public health and the associated economic burden. Obesity is a major risk factor for several conditions including cardiovascular disease and type 2 diabetes, and recent evidence suggests that obesity negatively affects cancer risk and outcome. The relationship between obesity and cancer is complex and involves multiple factors both at the systemic and cellular level...
22 CitationsSource
#1Paul E. Goss (Harvard University)H-Index: 72
#2JN Ingle (Mayo Clinic)H-Index: 24
Last. Wendy R. Parulekar (Queen's University)H-Index: 31
view all 20 authors...
Canadian Cancer Society Research Institute [021039, 015469]; National Cancer Institute [CA180888, CA189953, CA180828, CA13612, CA37981, CA077202, CA180863, CA67753, CA189805, CA16116, CA180802]; Canadian Cancer Trials Group [CA077202, CA180863]; ECOG-ACRIN Cancer Research Group [CA180820, CA21115]; Novartis Pharmaceuticals; Avon Foundation; AstraZeneca; Pfizer; Roche; Amgen; Novartis; Glaxo-SmithKline; Eisai; Genomic Health; NanoString; Genentech; BioMarin
203 CitationsSource
#1M. VitaleH-Index: 3
#2Maria MasulliH-Index: 15
Last. Olga VaccaroH-Index: 30
view all 37 authors...
Purpose The optimal macronutrient composition of the diet for the management of type 2 diabetes is debated, particularly with regard to the ideal proportion of fat and carbohydrates. The aim of the study was to explore the association of different proportions of fat and carbohydrates of the diet—within the ranges recommended by different guidelines—with metabolic risk factors.
24 CitationsSource
#1Cynthia A. Thomson (UA: University of Arizona)H-Index: 56
#2Linda Van Horn (NU: Northwestern University)H-Index: 80
Last. Ross L. Prentice (Fred Hutchinson Cancer Research Center)H-Index: 102
view all 14 authors...
25 CitationsSource
#1Edith A. Perez (Mayo Clinic)H-Index: 88
#2Edward H. Romond (UK: University of Kentucky)H-Index: 24
Last. Norman Wolmark (Allegheny General Hospital)H-Index: 85
view all 16 authors...
Purpose Positive interim analysis findings from four large adjuvant trials evaluating trastuzumab in patients with early-stage human epidermal growth factor receptor 2 (HER2) –positive breast cancer were first reported in 2005. One of these reports, the joint analysis of North Central Cancer Treatment Group NCCTG N9831 (Combination Chemotherapy With or Without Trastuzumab in Treating Women With HER2-Overexpressing Breast Cancer) and the National Surgical Adjuvant Breast and Bowel Project NSABP B...
305 CitationsSource
#1Caroline E. Boeke (Harvard University)H-Index: 12
#2A. Heather Eliassen (Harvard University)H-Index: 44
Last. Rulla M. Tamimi (Harvard University)H-Index: 60
view all 8 authors...
Whether fat intake influences risk of developing more aggressive, lethal breast tumors is unknown. We evaluated intakes of total fat, specific types of fat, and cholesterol prior to diagnosis in relation to lethal breast cancer risk in 88,759 women in the Nurses’ Health Study (NHS; 1980–2010) and 93,912 women in the Nurses’ Health Study II (NHSII; 1991–2010). Diet was assessed every 4 years using a semi-quantitative food frequency questionnaire. Breast cancers were confirmed with pathology repor...
14 CitationsSource
Cited By4
Newest
#1Yaser Sharif (Tehran University of Medical Sciences)H-Index: 1
#2Omid Sadeghi (Tehran University of Medical Sciences)H-Index: 9
Last. Ahmad Esmaillzadeh (Tehran University of Medical Sciences)H-Index: 53
view all 5 authors...
Previous studies on the association between legume and nuts intake and risk of breast cancer have mainly been focused on individual components of legume or nuts, rather than consumption of the whole food group. This study aimed to investigate the relation between legume and nuts intake in relation to breast cancer in Iranian women. In this population-based case-control study, we enrolled 350 pathologically confirmed new cases of breast cancer and 700 controls which were matched with cases in ter...
Source
#1Andrés Méndez-Lucas (Francis Crick Institute)H-Index: 3
#2Wei Lin (Francis Crick Institute)H-Index: 1
Last. Stephen Rayport (Columbia University)H-Index: 32
view all 16 authors...
Plasticity of cancer metabolism can be a major obstacle to efficient targeting of tumour-specific metabolic vulnerabilities. Here, we identify the compensatory mechanisms following the inhibition of major pathways of central carbon metabolism in c-MYC-induced liver tumours. We find that, while inhibition of both glutaminase isoforms (Gls1 and Gls2) in tumours considerably delays tumourigenesis, glutamine catabolism continues, owing to the action of amidotransferases. Synergistic inhibition of bo...
1 CitationsSource
Source
#1Marian L. Neuhouser (Fred Hutchinson Cancer Research Center)H-Index: 65
3 CitationsSource
#1Joanna Buscemi (UIC: University of Illinois at Chicago)H-Index: 19
#2Laura B. Oswald (NU: Northwestern University)H-Index: 1
Last. Betina Yanez (NU: Northwestern University)H-Index: 13
view all 10 authors...
Breast cancer is the most common cancer among Latina women, and Latina women are at higher risk for breast cancer mortality than white women. Lifestyle factors, such as consuming a nutritious diet and engaging in regular physical activity, promote health and are protective against heart disease, type 2 diabetes, and breast cancer recurrence. Previous studies have developed and tested interventions for Latina breast cancer survivors to improve diet and increase physical activity, however, no stud...
Source
#1Andrés Méndez-Lucas (Francis Crick Institute)H-Index: 3
#1Mariia Yuneva (Francis Crick Institute)H-Index: 8
Last. Xin Chen (UCSF: University of California, San Francisco)H-Index: 50
view all 16 authors...
Plasticity of cancer metabolism can be a major obstacle for efficient targeting of tumour-specific metabolic vulnerabilities. Here, we identify and quantify the compensatory mechanisms following the inhibition of major pathways of central carbon metabolism in c-MYC-induced liver tumours. We find that glutaminase isoform Gls2, expressed in normal liver, compensates for the deletion of Gls1 isoform expressed in tumours. Inhibiting both glutaminases significantly delays tumourigenesis but does not ...
Source
#1Lai Xu (WashU: Washington University in St. Louis)H-Index: 4
#2Lindsay L. Peterson (WashU: Washington University in St. Louis)H-Index: 8
Purpose of Review Breast cancer is the most common cancer in women, yet conclusive evidence of the effects of dietary modification in breast cancer survivors is lacking. Here, we summarize the literature and highlight important data regarding the association between dietary interventions and breast cancer outcomes.
1 CitationsSource
#1Ross L. Prentice (Fred Hutchinson Cancer Research Center)H-Index: 102
#2Aaron K. Aragaki (Fred Hutchinson Cancer Research Center)H-Index: 42
Last. Jacques E. RossouwH-Index: 47
view all 14 authors...
Background The preferred macronutrient dietary composition, and the health consequences of dietary fat reduction specifically, have been debated for decades. Here we provide a comprehensive overview of long-term health outcomes in the Women's Health Initiative Dietary Modification (DM) trial.
2 CitationsSource
#1Rowan T. Chlebowski (Los Angeles Biomedical Research Institute)H-Index: 80
#2Garnet L. Anderson (Fred Hutchinson Cancer Research Center)H-Index: 70
Last. Cynthia A. Thomson (UA: University of Arizona)H-Index: 56
view all 18 authors...
Background: In the Women's Health Initiative Dietary Modification trial, a low-fat dietary pattern reduced deaths after breast cancer. Mortality from other cancer sites has not been reported. Methods: A low-fat dietary pattern influence on deaths from and after site-specific cancers was examined during 8.5 years (median) of dietary intervention and cumulatively during 17.7 years (median) of follow-up. A total 48 835 postmenopausal women, ages 50-79 years, were randomly assigned from 1993 to 1998...
2 CitationsSource
Source